Navigation Links
United Therapeutics Reports Third Quarter 2007 Financial Results
Date:11/1/2007

nded September 30, 2007, as compared to approximately $5.6 million for the three months ended September 30, 2006. The income tax provision was based on the estimated annual effective tax rate for the entire year. The estimated annual effective tax rate is subject to adjustment in subsequent quarterly periods as the estimates of pre-tax income and permanent book to tax return differences for the year are adjusted. The estimated annual effective tax rates for the three months ended September 30, 2007 and 2006, were approximately 18 percent and 43 percent, respectively. In September 2007, we completed a detailed review of our 2006 research and development expenses in preparation for the filing of our 2006 tax returns. As a result of this review, we were able to claim greater amounts of business credits, a permanent book to tax difference, on our tax return than we had estimated at December 31, 2006. In addition, based on information learned in the review, we revised our estimate of the business credits expected to be generated from our 2007 research and development activities. The effect of both of these items resulted in a reduction of our estimated annual effective tax rate for 2007. We do not anticipate paying significant federal income taxes for 2007 due to the availability of approximately $19.8 million of net operating loss carryforwards and approximately $59.7 million of business tax credits.

Pro Forma Net Income

During the nine months ended September 30, 2006, we recognized a non-cash and non-recurring charge of $2.0 million for the impairment of the HeartBar tradename. During the nine months ended September 30, 2007, we issued 200,000 shares of our common stock to Toray Industries, Inc., in connection with our amended license agreement for modified release beraprost (beraprost-MR). The issuance of shares resulted in an $11.0 million non-recurring expense because the licensed product has not yet obtained regulatory approval for commercial sales. If
'/>"/>

SOURCE United Therapeutics Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Inacom Education earns Wisconsin membership in United Training
2. Canadian firm buys Proventiv Therapeutics, makes ex-Bone Care exec CEO
3. TomoTherapy reports 86% revenue jump, $131M net loss in Q1
4. Sonic Foundry reports GAAP loss as Q2 revenues rise
5. Fiserv reports $113.5 million in Q1 profit
6. Third Wave reports net loss of $18.9M for 2006
7. Musicnotes reports 45 percent growth in 2006
8. Sonic Foundry reports net loss, higher revenue
9. Sonic Foundry reports first cash-positive quarter
10. Merge Healthcare reports $10.8M net loss in Q3
11. Third Wave reports $5.2M third quarter loss
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... (PRWEB) September 17, 2014 NASA’s MESSENGER ... Valcor Engineering Corporation is proud to have one of ... The MESSENGER mission is a scientific investigation of the ... to be sent there, and has provided a vast ... Valcor’s V27200 family of latch valves utilize solenoids that ...
(Date:9/16/2014)... , Sept. 16, 2014 This report analyzes the ... Product Segments: Software, Hardware, and Biocontent. The report provides separate ... Japan , Europe , ... , and Rest of World. Annual estimates and forecasts are ... historic analysis is provided for these markets. Market data and ...
(Date:9/16/2014)... From cell phones to cars and flashlights, ... Scientists and technology companies constantly are seeking ways ... the first time using a water-based solution, researchers ... long-lasting and more efficient nuclear battery that could ... reliable energy source in automobiles and also in ...
(Date:9/16/2014)... , Sept. 16, 2014  Donald Fresne, President and ... of Stephan Vagner , PhD to its Scientific Advisory ... of Toulouse, France , performed research at ... , and at Inserm, the French institute of health and ... works both at the Curie Institute, Orsay, France ...
Breaking Biology Technology:Global Bioinformatics Industry 2Global Bioinformatics Industry 3Global Bioinformatics Industry 4Global Bioinformatics Industry 5Global Bioinformatics Industry 6Global Bioinformatics Industry 7Global Bioinformatics Industry 8Global Bioinformatics Industry 9Global Bioinformatics Industry 10Global Bioinformatics Industry 11Global Bioinformatics Industry 12Global Bioinformatics Industry 13Global Bioinformatics Industry 14Global Bioinformatics Industry 15Global Bioinformatics Industry 16Global Bioinformatics Industry 17Global Bioinformatics Industry 18Global Bioinformatics Industry 19Global Bioinformatics Industry 20Global Bioinformatics Industry 21Global Bioinformatics Industry 22Global Bioinformatics Industry 23New Appointment to the Scientific Advisory Committee at Egenix, Inc. 2
... Improve Diabetes Care, PERRYSBURG, Ohio, Feb. 25 ... medical, humanistic and financial elements of,diabetes care will ... (NBCH). FrontPath Health Coalition, through its non-profit Western,Lake ... lead this,community-wide effort that includes the City of ...
... NEW YORK, Feb. 25 Care to Care, a ... has signed,Touchstone Health HMO Inc. as a client. As ... portfolio has grown to over 700,000,lives., (Logo: ... and flattered to be selected as the Radiology,Benefit Manager ...
... One-year Agreement With Guaranteed Purchase Minimums - Carrington Provides ... ... Distribution, IRVING, Texas, Feb. 25 ... has signed,a supply agreement with Universal Harvest Corporation of Nevada. ...
Cached Biology Technology:FrontPath Health Coalition To Lead Community-wide Group in Pilot Program 2FrontPath Health Coalition To Lead Community-wide Group in Pilot Program 3Care to Care Begins Providing Radiology Benefit Management Services to Touchstone Health 2Carrington and Universal Harvest Sign Supply Agreement 2
(Date:9/16/2014)... "molecular brakes" that time the generation of important cells ... cells" translate sound waves into electrical signals that are ... If the arrangement of the cells is disordered, hearing ... will be published in The Journal of Neuroscience ... Hey2 act as brakes to prevent hair cell generation ...
(Date:9/16/2014)... inherit certain traits from our parents that are pre-determined. ... play out by taking certain drugs or better yet, ... team of researchers at the Boston University School of ... research. , Epigenetics regulates gene expression in a ... which prevent permanent mutations or alterations within the gene ...
(Date:9/16/2014)... its own bacterial identity. That,s the conclusion of University ... studied the genetic fingerprints of bacteria on 57 species ... study demonstrates for the first time that host plants ... possess very different microbial communities on their leaves," said ... in the UO,s Institute of Ecology and Evolution who ...
Breaking Biology News(10 mins):Hey1 and Hey2 ensure inner ear 'hair cells' are made at the right time, in the right place 2Epigenetic drugs: A hope to treat cancer resistance and reduce cancer relapse? 2Epigenetic drugs: A hope to treat cancer resistance and reduce cancer relapse? 3Microbiome research shows each tree species has a unique bacterial identity 2
... Joslin scientists report the first generation of human induced pluripotent ... maturity onset diabetes of the young (MODY). These cells offer ... in the development of MODY and testing potential treatments. The ... Human induced pluripotent stem cells (hiPSCs) are adult cells ...
... 2013 -- Deborah E. Wiley, Chair of The Wiley ... JWb), announced today that the twelfth annual Wiley Prize ... Young, Rockefeller University, Dr. Jeffrey Hall, Brandeis University (Emeritus), ... Prize is being awarded to Dr. Young, Dr. Hall ...
... Researchers from the group on stem cells and cancer at ... of the gene regulation circuits which would make it possible ... This finding is essential to generate these cells in a ... with leukaemia or other diseases who need a transplant and ...
Cached Biology News:Joslin scientists find first human iPSC from patients with maturity onset diabetes of the young 212th annual Wiley Prize in Biomedical Sciences awarded 212th annual Wiley Prize in Biomedical Sciences awarded 31 of the key circuits in regulating genes involved in producing blood stem cells is deciphered 2
Please email us with project details and we will respond within 24 hours to your query!...
Loading Buffer...
"BioTracker 6X Bromophenol Blue Tracking Dye is composed of 60% St DI H2O, 30% Glycerol, 10% 10XTE, 0.25% BPB Dye and 0.85% SDS....
Request Info...
Biology Products: